Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis

BACKGROUND: This pairwise meta-analysis determines the difference in bleeding risks associated with the use of novel oral anticoagulants (NOACs) and aspirin. METHODS: PubMed, the Cochrane Library database, clinicaltrial.gov, and related studies were searched for randomized control trials (RCTs) comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiehui, Huang, Weichao, Sun, Aimei, Wang, Lili, Mo, Fanrui, Guo, Wenqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487538/
https://www.ncbi.nlm.nih.gov/pubmed/34600549
http://dx.doi.org/10.1186/s12959-021-00322-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487538/
https://www.ncbi.nlm.nih.gov/pubmed/34600549
http://dx.doi.org/10.1186/s12959-021-00322-6

Ejemplares similares